AMP’s chief executive Craig Meller has resigned after this week’s shocking revelations that the company misled ASIC over fees charged to customers and may have […]
A lawyer for the University of Sydney has attacked ObjectiVision for failing to produce any commercial benefits from the glaucoma detection method at the centre […]
Expert witnesses were pitted against each other Wednesday at a trial alleging generic makers infringed a patent covering the anti-depressant Lexapro, and Apotex’ consultant took the […]
The maker of the anti-depressant Lexapro faced off Monday against Apotex, Aspen Pharma and Sandoz at a court hearing over the rights to make generic […]
In a long-running intellectual property fight with the University of Sydney, an expert witness for ophthalmic diagnostic device maker ObjectiVision has been grilled in the witness […]
Australian biotech company Holista Colltech has resolved litigation over ASX announcements that said it was collaborating with a Nobel Prize nominee to file a patent […]
Reckitt Benckiser Australia has lost a bid for an interim ban on a commercial by rival Procter & Gamble that claims Fairy Platinum dishwashing detergent […]
The Royal Bank of Scotland has agreed to pay $12.58 million to settle a consumer class action brought on behalf of purchasers of its financial […]
Sending an email of advice to third parties does not necessarily constitute waiver of legal professional privilege, a Federal Court judge has ruled, siding with […]
The Full Court has allowed Yazaki Corporation to file additional documents as it weighs the ACCC’s case that the auto parts maker got off easy […]